Bristol-Myers Squibb Company PFD CONV 2
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BMYMP research report →
About the company
Bristol-Myers Squibb is a pharmaceutical company dedicated to the research, development, and commercialization of treatments for a wide array of medical conditions. Its primary therapeutic domains include cardiovascular health, oncology, and immunological disorders. A significant strategic emphasis for the firm is immuno-oncology, an area where it has established itself as a leading innovator in developing new drugs.
- CEO
- Christopher S. Boerner
- IPO
- 2003
- Employees
- 34,100
- HQ
- Princeton, DE, US
Price Chart
- Market Cap
- $814.59B
- P/E
- 16.33
- P/S
- 2.45
- P/B
- 5.92
- EV/EBITDA
- 11.17
- Div Yield
- 4.32%
- Gross Margin
- 68.75%
- Op Margin
- 25.67%
- Net Margin
- 15.01%
- ROE
- 39.05%
- ROIC
- 13.55%
- Revenue
- $48.19B · -0.22%
- Net Income
- $7.05B · 178.82%
- EPS
- $3.46 · 178.46%
- Op Income
- $12.70B
- FCF YoY
- -7.87%
- 52W High
- $1050.00
- 52W Low
- $400.00
- 50D MA
- $945.27
- 200D MA
- $839.91
- Beta
- 0.27
- Avg Volume
- 2
Get TickerSpark's AI analysis on BMYMP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | YALE PHYLLIS R | other | 607.428 |
| Jun 30, 26 | Samuels Theodore R. II | other | 889.448 |
| Jun 30, 26 | Rice Derica W | other | 672.51 |
| Jun 30, 26 | McMullen Michael R. | other | 607.428 |
| Jun 30, 26 | Arduini Peter J | other | 607.428 |
| Jun 15, 26 | Haller Julia A | other | 20,460 |
| Jun 15, 26 | Haller Julia A | other | 20,460 |
| Jun 3, 26 | Short Bartie Wendy | other | 8,040 |
| Jun 3, 26 | Short Bartie Wendy | other | 3,876 |
| Jun 3, 26 | Short Bartie Wendy | other | 8,040 |
Our BMYMP coverage
Recent articles, reports, and earnings notes.
No research on BMYMP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BMYMP report →Similar companies
Peers in the same neighborhood.